1-5 of 5
Shunqiang Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer

Free
Shuying Liu, Shunqiang Li, Bailiang Wang, Wenbin Liu, Mihai Gagea, Huiqin Chen, Joohyuk Sohn, Napa Parinyanitikul, Tina Primeau, Kim-Anh Do, George F. Vande Woude, John Mendelsohn, Naoto T. Ueno, Gordon B. Mills, Debu Tripathy, Ana M. Gonzalez-Angulo
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2019) 18 (2): 399–412.
https://doi.org/10.1158/1535-7163.MCT-18-0710
Published: 04 February 2019
View articletitled, Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer
Open the PDF for Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Reactivation of p53 by MDM2 Inhibitor MI-77301 for the Treatment of Endocrine-Resistant Breast Cancer

Free
Jianfeng Lu, Donna McEachern, Shunqiang Li, Matthew J. Ellis, Shaomeng Wang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (12): 2887–2893.
https://doi.org/10.1158/1535-7163.MCT-16-0028
Published: 01 December 2016
View articletitled, Reactivation of p53 by MDM2 Inhibitor MI-77301 for the Treatment of Endocrine-Resistant Breast Cancer
Open the PDF for Reactivation of p53 by MDM2 Inhibitor MI-77301 for the Treatment of Endocrine-Resistant Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract C200: Effects of PI3K/Akt pathway inhibition on global proteome levels and phosphorylation signaling in patient-derived xenograft models of triple negative breast cancer

Free
Filip O. Mundt, Cynthia Ma, Philipp Mertins, Zhanfang Guo, Matthew Meyer, Jana Qiao, DR Mani, Karl Clauser, Shunqiang Li, Kuan Huang, Jason Held, Sherri Davies, Kelly Ruggles, Li Ding, Michael Gillette, David Fenyo, Reid Townsend, Matthew Ellis, Steven A. Carr
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): C200.
https://doi.org/10.1158/1535-7163.TARG-15-C200
Published: 01 December 2015
View articletitled, Abstract C200: Effects of PI3K/Akt pathway inhibition on global proteome levels and phosphorylation signaling in patient-derived xenograft models of triple negative breast cancer
Journal Articles

Combined Targeting of mTOR and AKT Is an Effective Strategy for Basal-like Breast Cancer in Patient-Derived Xenograft Models

Free
Siguang Xu, Shunqiang Li, Zhanfang Guo, Jingqin Luo, Matthew J. Ellis, Cynthia X. Ma
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (8): 1665–1675.
https://doi.org/10.1158/1535-7163.MCT-13-0159
Published: 08 August 2013
View articletitled, Combined Targeting of mTOR and AKT Is an Effective Strategy for Basal-like Breast Cancer in Patient-Derived Xenograft Models
Open the PDF for Combined Targeting of mTOR and AKT Is an Effective Strategy for Basal-like Breast Cancer in Patient-Derived Xenograft Models in another window
Includes: Supplementary data
Journal Articles

WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells

Free
Yaxiong Tang, Anne R. Simoneau, Wu-xiang Liao, Guo Yi, Christopher Hope, Feng Liu, Shunqiang Li, Jun Xie, Randall F. Holcombe, Frances A. Jurnak, Dan Mercola, Bang H. Hoang, Xiaolin Zi
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (2): 458–468.
https://doi.org/10.1158/1535-7163.MCT-08-0885
Published: 11 February 2009
View articletitled, WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells
Open the PDF for WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells in another window
Includes: Supplementary data